14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $84.70 $93.35 Wednesday, 24th Apr 2024 BMRN stock ended at $91.20. This is 0.93% less than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.20% from a day low at $91.01 to a day high of $93.02.
90 days $83.44 $94.15
52 weeks $76.02 $99.55

Historical BioMarin Pharmaceutical Inc. prices

Date Open High Low Close Volume
Jul 13, 2021 $81.99 $82.39 $81.22 $81.50 495 206
Jul 12, 2021 $83.84 $83.84 $81.81 $82.33 611 835
Jul 09, 2021 $83.13 $83.72 $82.79 $83.62 604 678
Jul 08, 2021 $82.26 $83.58 $81.50 $82.95 1 014 679
Jul 07, 2021 $84.75 $84.80 $82.88 $83.04 1 167 706
Jul 06, 2021 $85.35 $85.35 $84.00 $84.57 823 441
Jul 02, 2021 $84.23 $85.74 $83.46 $85.47 946 784
Jul 01, 2021 $83.26 $83.95 $82.97 $83.91 827 224
Jun 30, 2021 $83.42 $83.82 $82.75 $83.44 769 485
Jun 29, 2021 $84.23 $85.20 $82.96 $83.46 606 263
Jun 28, 2021 $85.79 $86.33 $83.87 $84.43 519 316
Jun 25, 2021 $84.33 $85.50 $83.20 $84.79 3 891 045
Jun 24, 2021 $83.23 $84.17 $82.91 $83.78 1 081 544
Jun 23, 2021 $80.79 $82.87 $80.79 $82.58 1 252 233
Jun 22, 2021 $80.92 $81.53 $80.14 $81.14 1 197 969
Jun 21, 2021 $82.06 $82.60 $80.43 $80.76 1 092 492
Jun 18, 2021 $82.54 $82.90 $81.52 $81.90 1 339 902
Jun 17, 2021 $82.54 $83.76 $82.04 $82.98 820 917
Jun 16, 2021 $82.13 $82.68 $81.35 $82.48 1 028 627
Jun 15, 2021 $82.40 $82.76 $81.19 $81.96 549 905
Jun 14, 2021 $82.49 $83.45 $82.17 $82.48 632 335
Jun 11, 2021 $83.55 $83.85 $81.75 $82.07 743 066
Jun 10, 2021 $82.46 $84.14 $81.83 $83.67 1 088 597
Jun 09, 2021 $79.46 $82.50 $79.27 $82.05 1 319 356
Jun 08, 2021 $79.17 $79.27 $78.00 $78.76 614 270
Click to get the best stock tips daily for free!

About BioMarin Pharmaceutical Inc.

BioMarin Pharmaceutical. BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-acetylgalactosamine 4-sulfatase for patients with MPS VI; and Kuvan, a proprietary synthetic oral form o... BMRN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT